4188.Two
4188.TWO operates in the healthcare equipment industry, manufacturing and distributing medical devices and equipment.
Business. 4188.TWO operates in the healthcare equipment industry, manufacturing and distributing medical devices and equipment.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
4188.TWO operates in the healthcare equipment industry, manufacturing and distributing medical devices and equipment.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. It holds significant liquidity with a current ratio of 22.62, supported by cash and equivalents of TWD 24.6 million. However, the company reported negative operating cash flow of TWD -47.06 million and free cash flow of TWD -56.75 million, suggesting operational inefficiencies and cash outflows.
Profitability metrics are concerning, with a return on equity of -10.69% and a return on assets of -8.95%. These figures fall significantly below the industry median for return on equity and return on assets, which are typically positive in the advanced medical equipment sector. The company's operating loss of TWD -87.93 million and net loss of TWD -55.72 million further underscore its financial challenges.
The company's revenue is concentrated in a single segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases exposure to market-specific risks and limits the company's ability to offset losses in one area with gains in another.
Growth trajectory is negative, with the company reporting a revenue of TWD 304.37 million in the latest period. The outlook for the current fiscal year indicates a continuation of this trend, with no significant revenue growth expected. The absence of capital expenditures beyond TWD -0.7 million suggests a lack of investment in future growth opportunities.
Risk factors include low liquidity and the potential for dilution, although no immediate filing-based liquidity or dilution flags were detected. The company's low debt levels and high cash reserves mitigate some financial risks, but the negative operating and free cash flows remain a concern. No dilution sources were identified in the available documents.
Recent events include the latest financial filing, which disclosed the company's significant operating and net losses. No recent earnings call transcripts or other material events were identified in the available data.
- The company has a low debt-to-equity ratio and high liquidity, but negative operating and free cash flows indicate operational inefficiencies.
- Profitability metrics are significantly below industry medians, with negative returns on equity and assets.
- Revenue is concentrated in a single segment, with no geographic diversification disclosed.
- Growth trajectory is negative, with no significant capital expenditures and no expected revenue growth in the current fiscal year.
- Risk factors include low liquidity and potential for dilution, although no immediate flags were detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 4188.TWO Market data — financials · 2026-05-26